Effect of the PainCoach App on Pain and Opiate Use After Total Knee Replacement

May 22, 2019 updated by: Kliniek ViaSana

Effect of the PainCoach App on Pain and Opiate Use in the First Two Weeks After Total Knee Replacement: Randomised Controlled Trial

Less is known about pain and opiate use at home directly after total knee replacement (TKR). Regarding side effects, low opiate use is desired. An e-health application, PainCoach app, was developed to guide patients in pain control and opiate use.

The aim of this study was to investigate the effect of the PainCoach app on pain and opiate use in TKR patients in the first two weeks at home after surgery. The hypothesis was that the use of this app would decrease pain and opiate use.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

97

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Planned for primary TKR

Exclusion Criteria:

  • No possession of a smartphone or tablet
  • Contra-indication to any of the pain medication used in the study
  • No email address
  • No internet at home
  • No thorough command of the Dutch language
  • Suffering from memory disorders
  • Surgery under general anaesthesia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PainCoach-app group
In the PainCoach-app group, in addition to receiving the aforementioned usual care, the PainCoach app was downloaded on each patient's smartphone or tablet. Patients could use this app whenever they wanted until day 14 after surgery. They were not subjected to any different treatment compared to the control group, i.e. advice on pain management was delivered in an extra and different way, but the pain medication itself was exactly the same for both groups.
In response to the patient's input of the pain experienced (no pain, bearable pain, unbearable pain, or untenable pain), the app gave advice on pain medication use, exercises/rest and when to call the clinic from day 1 until day 14 after surgery.
No Intervention: Control group
The control group received usual care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in pain at rest in the first two weeks at home after TKR
Time Frame: 14 measurement points: daily from day 1 to 14 after surgery
Pain at rest was daily measured with VAS from 0 (no pain) to 100 (worst imaginable pain)
14 measurement points: daily from day 1 to 14 after surgery
Change in pain during activity in the first two weeks at home after TKR
Time Frame: 14 measurement points: daily from day 1 to 14 after surgery
Measured with VAS from 0 (no pain) to 100 (worst imaginable pain)
14 measurement points: daily from day 1 to 14 after surgery
Change in pain at night in the first two weeks at home after TKR
Time Frame: 14 measurement points: daily from day 1 to 14 after surgery
Measured with VAS from 0 (no pain) to 100 (worst imaginable pain)
14 measurement points: daily from day 1 to 14 after surgery
Change in opiate use in the first two weeks at home after TKR
Time Frame: 14 measurement points: daily from day 1 to 14 after surgery
Oxycodon (5 mg per tablet) use was recorded in quantities per 24 hours
14 measurement points: daily from day 1 to 14 after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain at rest
Time Frame: 1 month after surgery
Measured with VAS from 0 (no pain) to 100 (worst imaginable pain)
1 month after surgery
Pain during activity
Time Frame: 1 month after surgery
Measured with VAS from 0 (no pain) to 100 (worst imaginable pain)
1 month after surgery
Pain at night
Time Frame: 1 month after surgery
Measured with VAS from 0 (no pain) to 100 (worst imaginable pain)
1 month after surgery
Change in other pain medication use in the first two weeks at home after TKR
Time Frame: 14 measurement points: daily from day 1 to 14 after surgery
i.e. NSAID (Diclofenac), acetaminophen and/or Gabapentin were recorded in quantities per 24 hours
14 measurement points: daily from day 1 to 14 after surgery
Change in pain acceptance at rest, during activity and at night in the first two weeks at home after TKR
Time Frame: 14 measurement points: daily from day 1 to 14, and at 1 month after surgery
Measured with a happy smiley (acceptable pain) and a sad smiley (unacceptable pain)
14 measurement points: daily from day 1 to 14, and at 1 month after surgery
Change in experiences with the executed recommended physiotherapy exercises in the first two weeks at home after TKR
Time Frame: 14 measurement points: daily from day 1 to 14 after surgery
Measured on a 3-item scale; did too much, exactly enough, or could have done more exercises
14 measurement points: daily from day 1 to 14 after surgery
Function
Time Frame: 1 month after surgery
Measured with the Knee injury and Osteoarthritis Outcome Score - Physical Function Short-form (KOOS-PS) with a total score from 0 (no difficulty) to 100 (extreme difficulty)
1 month after surgery
Function and pain
Time Frame: 1 month after surgery
Measured with the Oxford Knee Score (OKS) with a total score from 0 (most severe symptoms) to 48 (least severe symptoms)
1 month after surgery
Quality of life
Time Frame: 1 month after surgery
Measured with the EuroQol-5D 3 level version (EQ-5D-3L) consisting of two scores: EQ Visual Analogue Scale (EQ VAS) score from 0 (worst imaginable health state) to 100 (best imaginable health state), and EQ-5D descriptive system (EQ-5D index).
1 month after surgery
PainCoach app's perceived effectiveness
Time Frame: Day 14 after surgery
Usability, added value, and likelihood of being recommended to others was recorded on a 5-item scale ranging from totally agree to totally disagree
Day 14 after surgery
Active PainCoach app use
Time Frame: From day 1 to 14 after surgery
Measured with recording the actual amount of app use and defining active use as at least 12 times in total
From day 1 to 14 after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: J.M. Brinkman, MD, PhD, Kliniek ViaSana

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 15, 2016

Primary Completion (Actual)

July 6, 2016

Study Completion (Actual)

June 8, 2017

Study Registration Dates

First Submitted

May 14, 2019

First Submitted That Met QC Criteria

May 22, 2019

First Posted (Actual)

May 23, 2019

Study Record Updates

Last Update Posted (Actual)

May 23, 2019

Last Update Submitted That Met QC Criteria

May 22, 2019

Last Verified

May 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • PainCoach app study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on PainCoach app

Subscribe